Design, synthesis and antidepressant activities of some novel fatty acid analogues

[1]  S. Sankar,et al.  Docking Studies, Synthesis, Characterization of Some Novel Oxazine Substituted 9‐Anilinoacridine Derivatives and Evaluation for Their Antioxidant and Anticancer Activities as Topoisomerase II Inhibitors. , 2013 .

[2]  K. Elango,et al.  Synthesis and characterization of some novel fatty acid analogues: A preliminary investigation on their activity against human lung carcinoma cell line , 2013, Lipids in Health and Disease.

[3]  M. Bhaskar,et al.  Molecular modeling, docking and ADMET studies towards development of novel Disopyramide analogs for potential inhibition of human voltage gated sodium channel proteins , 2012, Bioinformation.

[4]  S. Sankar,et al.  Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors. , 2012, European journal of medicinal chemistry.

[5]  P. Dhanabal,et al.  Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues. , 2012, European journal of medicinal chemistry.

[6]  S. Jubie,et al.  Synthesis and Neuropharmacological Evaluation of Some Novel Quinoxaline 2, 3-Dione Derivatives , 2012, TheScientificWorldJournal.

[7]  K. Elango,et al.  Synthesis and biological evaluation of some schiff bases of [4-(amino)-5-phenyl-4H-1, 2,4-triazole-3-thiol]. , 2011, Pakistan journal of pharmaceutical sciences.

[8]  R. Kumar,et al.  Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives. , 2011, European journal of medicinal chemistry.

[9]  N. Sterin-Speziale,et al.  Potentiation of omega-3 fatty acid antidepressant-like effects with low non-antidepressant doses of fluoxetine and mirtazapine. , 2010, European journal of pharmacology.

[10]  Anupam Sharma,et al.  A new anxiolytic fatty acid from Aethusa cynapium. , 2010, Fitoterapia.

[11]  Z. Kaplancıklı,et al.  New pyrazoline derivatives and their antidepressant activity. , 2010, European journal of medicinal chemistry.

[12]  Basappa,et al.  Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain , 2010, PloS one.

[13]  C. Nemeroff,et al.  Emerging targets for antidepressant therapies. , 2009, Current opinion in chemical biology.

[14]  S. Keshavarz,et al.  Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder , 2008, The Australian and New Zealand journal of psychiatry.

[15]  T. Peters,et al.  No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial , 2008, British Journal of Nutrition.

[16]  R. P. Agrawal,et al.  Omega-3 fatty acids have antidepressant activity in forced swimming test in Wistar rats. , 2007, Acta poloniae pharmaceutica.

[17]  Ulf Norinder,et al.  Prediction of ADMET Properties , 2006, ChemMedChem.

[18]  R. Belmaker,et al.  Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. , 2006, The American journal of psychiatry.

[19]  T. Langer,et al.  Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors. , 2006, Current Medicinal Chemistry.

[20]  G. Papakostas.  Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder. , 2005, Essential psychopharmacology.

[21]  Andrea Mattevi,et al.  Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Belmaker,et al.  Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.

[23]  A. Cagnotto,et al.  [1,2,4]Triazole derivatives as 5-HT(1A) serotonin receptor ligands. , 2002, Bioorganic & medicinal chemistry.

[24]  M. Fava.  Augmentation and combination strategies in treatment-resistant depression. , 2001, The Journal of clinical psychiatry.

[25]  D. Erol,et al.  Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. , 2001, European journal of medicinal chemistry.

[26]  W. Katon,et al.  The Role of the Primary Care Physician in Patients' Adherence to Antidepressant Therapy , 1995, Medical care.

[27]  J. Kane,et al.  2,4-Dihydro-3H-1,2,4-triazole-3-thiones as potential antidepressant agents. , 1988, Journal of medicinal chemistry.